Disagree and looks pretty bad either way.
PGL spends A$50M cash to buy one Phase III HIV project. Who will buy HIV drug? Only the patients who can get the health insurance from Government or/and Company. HIV durgs are in the big markets in Indutrised countries.
AVX in fact does an A$50m placement at 6.34 cents per share (A$0.82 from current PGL share price / 12.837 ratio), a 39% discount to its share price at 10.5cents last Friday!